DHR

Business Context and Reporting Period

Company: Danaher Corporation
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2004
Business Overview: Danaher designs, manufactures, and markets industrial and consumer products across three segments: Professional Instrumentation, Industrial Technologies, and Tools & Components. The company utilizes the Danaher Business System (DBS) to drive performance and pursues strategic acquisitions to expand market positions. In 2004, the company reorganized its reporting structure from two to three segments.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth Drivers: Consolidated revenue increased 30% year-over-year. Acquisitions accounted for approximately 18.5% of growth, favorable currency translation (primarily Euro strength) contributed 2.5%, and organic growth from existing businesses contributed 9%.
• Segment Performance:
  • Professional Instrumentation: Sales grew 52% to $2.9 billion, driven largely by the acquisition of Radiometer, KaVo, and Gendex (forming a new Medical Technology line) and Trojan Technologies.
  • Industrial Technologies: Sales grew 22.5% to $2.7 billion, driven by acquisitions in product identification and strong organic growth in motion businesses.
  • Tools & Components: Sales grew 9% to $1.3 billion, driven by volume increases in hand tools and niche businesses.
• Acquisition Activity: The company spent approximately $1.6 billion in cash on 13 acquisitions in 2004, significantly reducing cash balances from $1.23 billion in 2003 to $609 million in 2004.
• Margin Expansion: Gross profit margin improved 160 basis points to 42.0%, driven by sales volume leverage and higher margins in acquired businesses, partially offset by raw material cost increases (steel).

Guidance, Outlook, and Risks

• Outlook: Management expects certain businesses to experience moderating growth in 2005 due to global economic conditions, a slowing semiconductor market, and difficult comparisons to the strong 2004 performance. The company anticipates capital spending of approximately $150 million in 2005.
• Tax Strategy: The effective tax rate for 2004 was 29.5%. Management expects the rate to decrease to 27.5% in 2005 due to a higher proportion of international earnings. The company currently has no intention to repatriate foreign earnings under the American Jobs Creation Act of 2004.
• Debt Maturity: $407 million in Eurobond notes mature in July 2005. The company plans to satisfy this obligation using available cash, commercial paper, or credit facilities.
• Key Risks:
  • Integration of acquired businesses and realization of synergies.
  • Fluctuations in foreign currency exchange rates (exposure to Euro and other currencies).
  • Raw material costs and supply constraints (specifically steel and petroleum-based products).
  • Regulatory compliance regarding environmental remediation (e.g., Joslyn Manufacturing Company liabilities) and medical device regulations (FDA).
  • Patent infringement litigation (e.g., Raytek Corporation case).

Investor Verification Checklist

• Acquisition Integration: Verify the progress of integrating major 2004 acquisitions (Radiometer, KaVo, Trojan) and the realization of projected synergies.
• Debt Refinancing: Monitor the company's ability to refinance or repay the $407 million Eurobond notes maturing in July 2005.
• Raw Material Costs: Track the impact of steel and commodity price increases on gross margins and the effectiveness of price pass-throughs to customers.
• Environmental Liabilities: Review updates on remediation costs for former Joslyn Manufacturing Company sites and other environmental contingencies.
• Stock-Based Compensation: Note the upcoming adoption of SFAS No. 123R in 2005, which will require expensing the fair value of stock options, potentially impacting reported earnings.